HEALTHEURACTIV
FIRST AID: Patents or patients?
The article discusses the tension between drug patents and patient access, focusing on health technology assessment (HTA) and European Council (EUCO) considerations. It highlights drugs, HTA, and EUCO as key elements in the debate.
Related Signal
Adjacent reporting
- STAT+: Where patients and hospitals disagree about AI
- Patents or patients? Two camps form over EU’s new pharma perks
- Why Has There Been So Little Progress on Alzheimer's Disease?
- Influencers vs evidence-based medicine (part one)
- STAT+: Did AI really beat doctors at diagnosis?
- The Download: whole-body rejuvenation drugs and five things to know about AI